SCHEMBL4045594

SCHEMBL4045594

CC(C)(C)OC(=O)N1CC(C(=O)Nc2nccnc2N)C1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
PTPN6 P29350 1/20 0.44
ABL1 P00519 1/20 0.42
RIN1 Q13671 1/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
BUB1 O43683 1/20 0.40
GPR119 Q8TDV5 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
USP30 Q70CQ3 2/20 0.39
PTPN11 Q06124 1/20 0.38
JAK1 P23458 1/20 0.37
JAK3 P52333 1/20 0.37
KMT2A Q03164 1/20 0.37
NAMPT P43490 1/20 0.37
NR1H2 P55055 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22763030 0.81 USP2 (0.38) PTPN2PTPN1PTPN6GPR119USP30
SCHEMBL4041214 0.80 NEK2 (0.38) HDAC1HDAC2NPC1RAB9A
SCHEMBL30585823 0.77 PTPN2 (0.46) PTPN2PTPN1PTPN6ABL1RIN1
SCHEMBL21639881 0.77 PTPN2 (0.46) PTPN2PTPN1PTPN6ABL1RIN1
SCHEMBL31596935 0.77 PTPN2 (0.52) PTPN2PTPN1PTPN6ABL1RIN1
SCHEMBL4911832 0.77 LMNA (0.51) PTPN2PTPN1PTPN6ABL1RIN1
SCHEMBL21641259 0.74 PTPN2 (0.43) PTPN2PTPN1PTPN6ABL1RIN1
SCHEMBL5492751 0.74 NTRK1 (0.44) PTPN2PTPN1PTPN6ABL1RIN1
SCHEMBL21640304 0.73 PTPN2 (0.50) PTPN2PTPN1PTPN6ABL1RIN1
SCHEMBL21640789 0.73 DEGS1 (0.54) PTPN2PTPN1PTPN6ABL1RIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009029592-A1 HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed
WO-2009029592-A1 HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed